14 November 2017
URGO Group continues its rapid growth in Latin America with the acquisition of Chilean medical devices company Optivision
- Acquisition of Optivision, a leading Chilean company specialized in the distribution of wound care products, orthopedic and medical equipment
- With this third acquisition in the region, after Colombia (Gerco in 2016) and Brazil (LM Farma in 2011) URGO Group is strongly reinforcing its strategic position in advanced wound care and consumer healthcare in Latin America
Santiago de Chile/Paris, November 14, 2017 – French family-owned international healthcare group URGO, a global leader in Advanced Wound Care (AWC) and Consumer Healthcare, is announcing today the acquisition of family-owned Optivision, a medical care pioneer actor on the Chilean market. This acquisition was announced at the occasion of the visit to Chile of Pierre Moustial, CEO of URGO Group.
The Group has been present in the country since 2006, forging a long-term and historical cooperation with its distributor Optivision. As global experts in the Advanced Would Care market, URGO Group and Optivision will dedicate their joint efforts to work hand in hand to set the highest standards for wound care treatments provided to patients across the country.
Employing 28 people and directed by Ivan Chandia, the company distributes locally three range of products through the brands Urgo Medical (Advanced Wound Care with high-tech dressings, compression bands), Clinicare (medical commodities) and Euromedica (medical equipments). The company was founded in 1998 and its offices and distribution center are based in Santiago de Chile.
URGO-OPTIVISION strategy in Chile
Like in other Latin-American countries, Chile faces many healthcare challenges and the Chilean population is not spared by the Chronic or Acute wound burden, especially with a rising number of diabetic patients. URGO-OPTIVISION will therefore continue distributing Urgo Medical’s solutions in Advanced Wound Care and answer to the patient needs by providing:
- The most appropriate dressings and specific treatment protocols for each type of acute and chronic wounds (diabetic foot ulcer, venous leg ulcer, pressure ulcer, Epidermolysis Bullosa disease, Burns…)
- Medical trainings to continue improving care and treatment for patients in Chile (awareness-heightening actions with medical and nursing staff such as e-learning trainings on specific chronic wounds pathologies)
- The rolling-out of the company’s last innovative solutions for optimising the care and treatment pathway. URGO Group is developing digital solutions, namely Eureka, which provides healthcare professionals assistance with diagnosis, customised treatments and care protocols, a monitoring of wounds with alerts on the healing trajectory
URGO Group is pursuing its active internationalisation policy and made 45% of its turnover abroad in 2016. With a direct presence in more than 22 countries and products in more than 60, URGO Group has decided to continue its rapid growth in Latin America, a priority for the Group.
URGO Group acquired GERCO in Colombia (OTC market) in 2016 and LM Farma (with its famous brand Curatec) in 2012 in Brazil.
“We are glad to strengthen our presence in Chile, with the pioneering experience of Optivision, with whom we have been working for more than ten years. URGO Group will continue to provide Optivision, leading company on the Chilean wound care market, with Urgo Medical treatment and products. Our ambition and mission in Chile is to develop innovative solutions to help healthcare professionals to reduce healing time. With this acquisition, we are also confident that it will reinforce our synergies and enable URGO-OPTIVISION to fasten its development on the national and regional advanced wound care markets.” said Pierre Moustial, URGO Group’s CEO.
“For Optivision, Chilean family company founded in 1998, it is a great opportunity to join now French multinational company Urgo Group to keep developing access of innovative Advanced Wound Care solutions and products in Chile and in rest of Latin America. Within URGO Group, Optivision will keep working intensively with Chilean Healthcare professionals in Acute and especially in Chronic Wounds, such as Diabetic Foot Ulcer, with breakthrough technology” said Ivan Chandia, Managing Director of Optivision.